13th Aug 2024 7:00 am |
RNS |
Cancellation - Destiny Pharma plc |
12th Aug 2024 7:00 am |
RNS |
Last Day of Dealings on AIM |
5th Aug 2024 11:58 am |
RNS |
Director/PDMR Shareholding |
31st Jul 2024 11:00 am |
RNS |
Result of GM and Cancellation of Trading on AIM |
15th Jul 2024 7:00 am |
RNS |
Proposed Cancellation of Admission to Trading |
20th Jun 2024 7:00 am |
RNS |
Exercise of Options and Total Voting Rights |
18th Jun 2024 7:00 am |
RNS |
Efficacy of XF-70 in Fungal Skin Infections |
12th Jun 2024 12:16 pm |
RNS |
Result of Annual General Meeting |
12th Jun 2024 11:00 am |
RNS |
2024 Annual General Meeting and Statement |
11th Jun 2024 7:00 am |
RNS |
Destiny Pharma's XF-73 Nasal Awarded MHRA ILAP |
24th May 2024 7:00 am |
RNS |
Exercise of Options and Total Voting Rights |
9th May 2024 2:35 pm |
RNS |
Posting of Annual Report and Notice of AGM |
25th Apr 2024 7:00 am |
RNS |
Full year results and review of strategic options |
8th Apr 2024 7:00 am |
RNS |
Notice of Full Year Results |
19th Mar 2024 2:47 pm |
RNS |
Exercise of Options and Total Voting Rights |
31st Jan 2024 7:00 am |
RNS |
Clinical development update |
22nd Jan 2024 7:00 am |
RNS |
Appointment of Nominated Adviser and Sole Broker |
4th Jan 2024 7:00 am |
RNS |
Year End Business Update |
20th Oct 2023 7:00 am |
RNS |
Grant of Share Options |
19th Oct 2023 7:00 am |
RNS |
Director/PDMR Shareholding |
17th Oct 2023 7:01 am |
RNS |
XF Pipeline Update Meeting |
17th Oct 2023 7:00 am |
RNS |
Publication of new microbiological data for XF-73 |
10th Oct 2023 7:00 am |
RNS |
Director/PDMR Shareholding |
4th Oct 2023 12:34 pm |
RNS |
Director/PDMR Shareholding |
27th Sep 2023 7:00 am |
RNS |
Notice of XF Pipeline Update Meeting |
20th Sep 2023 7:00 am |
RNS |
Interim Results |
23rd Aug 2023 7:00 am |
RNS |
Notice of Interim Results |
31st Jul 2023 12:01 pm |
RNS |
Publication of new data for XF-73 |
25th Jul 2023 7:00 am |
RNS |
Appointment of new Chairman |
19th Jul 2023 12:55 pm |
RNS |
Board changes including appointment of new CEO |
7th Jul 2023 7:00 am |
RNS |
Exercise of Options and Total Voting Rights |
6th Jul 2023 7:00 am |
RNS |
Positive findings from recent SAB meeting |
29th Jun 2023 7:00 am |
RNS |
Business Update |
26th May 2023 3:27 pm |
RNS |
Director/PDMR Shareholding |
26th May 2023 7:00 am |
RNS |
Director Dealing |
25th May 2023 12:23 pm |
RNS |
Result of Annual General Meeting |
25th May 2023 7:00 am |
RNS |
Dr Debra Barker Appointed Interim CEO |
12th May 2023 12:24 pm |
RNS |
Grant of Share Options |
2nd May 2023 7:00 am |
RNS |
Positive results from SPOR-COV® research |
26th Apr 2023 4:10 pm |
RNS |
Posting of Annual Report and Notice of AGM |